Syed H Haider1,2, Assad Oskuei1, George Crowley1, Sophia Kwon1, Rachel Lam1, Jessica Riggs1, Mena Mikhail1, Angela Talusan1, Arul Veerappan1, James S Kim1, Erin J Caraher1, Anna Nolan3,2,4. 1. Dept of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, New York, NY, USA. 2. Bureau of Health Services and Office of Medical Affairs, Fire Department of New York, New York, NY, USA. 3. Dept of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, New York, NY, USA anna.nolan@med.nyu.edu. 4. Dept of Environmental Medicine, New York University School of Medicine, New York, NY, USA.
Abstract
BACKGROUND: Our group has identified the receptor for advanced glycation end-products (RAGE) as a predictor of World Trade Center particulate matter associated lung injury. The aim of this systematic review is to assess the relationship between RAGE and obstructive airways disease secondary to environmental exposure. METHODS: A comprehensive search using PubMed and Embase was performed on January 5, 2018 utilising keywords focusing on environmental exposure, obstructive airways disease and RAGE and was registered with PROSPERO (CRD42018093834). We included original human research studies in English, focusing on pulmonary end-points associated with RAGE and environmental exposure. RESULTS: A total of 213 studies were identified by the initial search. After removing the duplicates and applying inclusion and exclusion criteria, we screened the titles and abstracts of 61 studies. Finally, 19 full-text articles were included. The exposures discussed in these articles include particulate matter (n=2) and cigarette smoke (n=17). CONCLUSION: RAGE is a mediator of inflammation associated end-organ dysfunction such as obstructive airways disease. Soluble RAGE, a decoy receptor, may have a protective effect in some pulmonary processes. Overall, RAGE is biologically relevant in environmental exposure associated lung disease. Future investigations should focus on further understanding the role and therapeutic potential of RAGE in particulate matter exposure associated lung disease.
BACKGROUND: Our group has identified the receptor for advanced glycation end-products (RAGE) as a predictor of World Trade Center particulate matter associated lung injury. The aim of this systematic review is to assess the relationship between RAGE and obstructive airways disease secondary to environmental exposure. METHODS: A comprehensive search using PubMed and Embase was performed on January 5, 2018 utilising keywords focusing on environmental exposure, obstructive airways disease and RAGE and was registered with PROSPERO (CRD42018093834). We included original human research studies in English, focusing on pulmonary end-points associated with RAGE and environmental exposure. RESULTS: A total of 213 studies were identified by the initial search. After removing the duplicates and applying inclusion and exclusion criteria, we screened the titles and abstracts of 61 studies. Finally, 19 full-text articles were included. The exposures discussed in these articles include particulate matter (n=2) and cigarette smoke (n=17). CONCLUSION:RAGE is a mediator of inflammation associated end-organ dysfunction such as obstructive airways disease. Soluble RAGE, a decoy receptor, may have a protective effect in some pulmonary processes. Overall, RAGE is biologically relevant in environmental exposure associated lung disease. Future investigations should focus on further understanding the role and therapeutic potential of RAGE in particulate matter exposure associated lung disease.
Authors: F Katsuoka; Y Kawakami; T Arai; H Imuta; M Fujiwara; H Kanma; K Yamashita Journal: Biochem Biophys Res Commun Date: 1997-09-18 Impact factor: 3.575
Authors: Maria B Sukkar; Md Ashik Ullah; Wan Jun Gan; Peter A B Wark; Kian Fan Chung; J Margaret Hughes; Carol L Armour; Simon Phipps Journal: Br J Pharmacol Date: 2012-11 Impact factor: 8.739
Authors: Megan Hardin; Jan Zielinski; Emily S Wan; Craig P Hersh; Peter J Castaldi; Eric Schwinder; Iwona Hawrylkiewicz; Pawel Sliwinski; Michael H Cho; Edwin K Silverman Journal: Am J Respir Cell Mol Biol Date: 2012-03-29 Impact factor: 6.914
Authors: Bushra Naveed; Michael D Weiden; Sophia Kwon; Edward J Gracely; Ashley L Comfort; Natalia Ferrier; Kusali J Kasturiarachchi; Hillel W Cohen; Thomas K Aldrich; William N Rom; Kerry Kelly; David J Prezant; Anna Nolan Journal: Am J Respir Crit Care Med Date: 2011-11-17 Impact factor: 21.405
Authors: P Yin; C Q Jiang; K K Cheng; T H Lam; K H Lam; M R Miller; W S Zhang; G N Thomas; P Adab Journal: Lancet Date: 2007-09-01 Impact factor: 79.321
Authors: Jun Tsukiji; Soo Jung Cho; Ghislaine C Echevarria; Sophia Kwon; Phillip Joseph; Edward J Schenck; Bushra Naveed; David J Prezant; William N Rom; Ann Marie Schmidt; Michael D Weiden; Anna Nolan Journal: Biomarkers Date: 2014-02-19 Impact factor: 2.658
Authors: Debra A Cockayne; Donavan T Cheng; Benjamin Waschki; Sriram Sridhar; Palanikumar Ravindran; Holly Hilton; Galina Kourteva; Hans Bitter; Sreekumar G Pillai; Sudha Visvanathan; Kai-Christian Müller; Olaf Holz; Helgo Magnussen; Henrik Watz; Jay S Fine Journal: PLoS One Date: 2012-06-12 Impact factor: 3.240
Authors: Eitan M Akirav; Octavian Henegariu; Paula Preston-Hurlburt; Ann Marie Schmidt; Raphael Clynes; Kevan C Herold Journal: PLoS One Date: 2014-04-23 Impact factor: 3.240
Authors: Gabriele Grunig; Nedim Durmus; Yian Zhang; Yuting Lu; Sultan Pehlivan; Yuyan Wang; Kathleen Doo; Maria L Cotrina-Vidal; Roberta Goldring; Kenneth I Berger; Mengling Liu; Yongzhao Shao; Joan Reibman Journal: Int J Environ Res Public Health Date: 2022-07-01 Impact factor: 4.614